behavioral-treatment | CARLAT PUBLISHING

The MTA Turns 21: Implications for ADHD Treatment

March 12, 2021

Anthony Charuvastra, MD Dr. Charuvastra has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The MTA was a classic research effort aimed at reaching more definitive conclusions about the relative effectiveness of stimulant medications and behavioral treatments for children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD). The results have proven enduring and inspiring, leading to the development of new and innovative treatment approaches.

EXPERT Q&A

Opioid Use Disorders and Serious Mental Illness

December 10, 2020

Sandra Gomez-Luna, MD

Sandra Gomez-Luna, MD
Clinical Assistant Professor at Yale University. Adult, adolescent, and child psychiatrist in Darien, CT. Dr. Gomez-Luna has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Those with serious mental illness and unhealthy opioid use have special treatment considerations due to polypharmacy and overlapping stigma. Dr. Gomez-Luna walks us through these nuances and explains microdosing of buprenorphine—a helpful technique for starting treatment in patients who may have other opioids on board.

EXPERT Q&A

Side Effects of Psychotherapy

November 12, 2020

Michael Linden, MD, PhD

Michael Linden, MD, PhD
Professor of psychiatry and director of psychosomatic research at the Charité University Medicine Berlin, Germany. Dr. Linden has dual training as a psychologist and psychiatrist and is licensed as a cognitive behavior therapist. He has helped develop new branches of CBT, and his research has brought recognition to the potential side effects of psychotherapy. Dr. Linden has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Psychotherapy can work as well as medication, but can it also have side effects? Michael Linden believes it can. He launched some of the key studies that brought light to this under-appreciated phenomenon, and in this interview he shows us how to recognize and avoid them.

Brief Therapy During the Medication Visit

November 12, 2020

Donna Sudak, MD

Donna Sudak, MD

Professor and Vice Chair for Education and Drexel University College of Medicine. She is the author of four books on psychotherapy, including Combining CBT and Medication: An Evidence-Based Approach (Wiley, 2011). Dr. Sudak has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Every minute counts in the 90833 “brief therapy with medication” visit, and Donna Sudak shows us how to customize CBT with pharmacotherapy for depression, bipolar, anxiety disorders, and schizophrenia.

Is AA the Toast of the Town?

October 21, 2020

Edmund S. Higgins, MD.

Edmund Higgins, MD Dr. Higgins has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Alcoholics Anonymous is one of the most prevalent treatments for alcohol use disorder, but claims of its effectiveness has been mired by limited evidence. This updated Cochrane meta-analysis tells a fuller story and offers suggestions for supporting patients utilizing this ubiquitous program.